Comparable outcomes different toxicities with anastrozole tamoxifen in DCIS Ivana Sestak

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> DOWNLOAD LINK 🎵 MP3 <<

############################# Video Source: www.youtube.com/watch?v=tje65w9GJms

Ivana Sestak puts the long-term results of the IBIS-II trial in the context of the NSABP B-35 study, both of which compared anastrozole with tamoxifen for breast cancer prevention in postmenopausal women with HR-positive ductal carcinoma in situ (3:39). • View more on Medicine Matters oncology: https://bit.ly/sabcs20

#############################